Australia and CEPI

Australia’s contributions to CEPI

CEPI, the Coalition for Epidemic Preparedness Innovations, was established in 2017 in the wake of Western African Ebola epidemic. It is a global effort that brings together public, private, philanthropic, and civil society organisations to develop vaccines for epidemics. Its works centre around three strategic focuses: preparedness, response and sustainability. CEPI was one of the first organizations to start developing COVID-19 vaccines in early 2020, and has been co-leading the COVAX facility with Gavi and WHO.

CEPI’s first strategic five-year plan covers from 2017 to 2021. It has received total commitments of 2.61 billion USD. Australia contributed US$10 million (AU$12 million), about only 0.4% of US$2.33 billion committed by government donors and ranked 14th. Australia’s contributions to the plan was only AU$4.5 million initially, but added another AU$7.5 million in 2020 as part of Australia’s Coronavirus Global Response pledge package.

In CEPI’s latest replenishment for the period from 2022 to 2026, it seeks to raise US$3.5 billion to speed up vaccine development, strengthen health systems and support global collaboration.

As of July 6 2022, CEPI has received US$1.3 billion commitments towards its 2022-2026 target, with US$0.97 billion of that contributed by government donors. Australia has significantly increased its supports to CEPI. It has pledged US$74 million (AU$100 million) and is placed at 6th among government donors in this round of funding. Australia’s contributions to CEPI will be split equally between DFAT and Health Department. Half of the contributions will be ODA-eligible.